{"title": "Caracter\u00edsticas sobre el consumo de plantas medicinales en pacientes que reciben Tratamiento Antirretroviral de Gran Actividad en un hospital nacional", "author": "Kimberly Rashel Ch\u00e1vez Bravo; Joseph Arthuro Pinto Oblitas", "url": null, "hostname": null, "description": "Introduction: Medicinal plants can generate drug interactions with antiretroviral treatment. Objective: To determine the characteristics of the consumption of medicinal plants in patients receiving highly active antiretroviral therapy treatment (HAART) in the Arzobispo Loayza National Hospital during 2019. Materials and methods: Observational, descriptive, cross-sectional study, carried out in 294 patients with diagnosis of human immunodeficiency virus infection receiving HAART in a Peruvian national referral hospital. The instrument used was a questionnaire with content validation by expert judgment. Results: The average age was 38.7 years, with a predominance of the male gender in 83.3%, from Lima Centro in 60.2%, with a degree of secondary education in 44.2%. 59.2% were diagnosed in the period 2014-2018. It was found that 67.7% of the patients consume medicinal plants, including garlic, chamomile, eucalyptus and cat\u2019s claw. Regarding antiretroviral treatment, 63.4% were receiving two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor. Conclusion: The characteristics of the consumption of medicinal plants in patients receiving antiretroviral treatment were determined, who mostly used them, where the main ones were chamomile, garlic, eucalyptus, cat\u2019s claw and aloe vera; With this, it was also possible to identify 15 cases where there was a probable drug interaction with cat\u2019s claw and garlic.", "sitename": "Revista Peruana de Medicina Integrativa", "date": "2022-09-30", "id": null, "license": "CC BY 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Caracter\u00edsticas sobre el consumo de plantas medicinales en pacientes que reciben Tratamiento Antirretroviral de Gran Actividad en un hospital nacional\nDOI:\n[https://doi.org/10.26722/rpmi.2022.v7n3.13](https://doi.org/10.26722/rpmi.2022.v7n3.13)\nPalabras clave:Plantas Medicinales, Terapia Antirretroviral Altamente Activa, Interacciones Farmacol\u00f3gicas, VIH\nResumen\nIntroducci\u00f3n: Las plantas medicinales pueden generar interacciones farmacol\u00f3gicas con el tratamiento antirretroviral de gran actividad (TARGA). Objetivo: Determinar las caracter\u00edsticas sobre el consumo de plantas medicinales en pacientes que reciben tratamiento antirretroviral de gran actividad atendidos en el Hospital Nacional Arzobispo Loayza durante el a\u00f1o 2019. Materiales y m\u00e9todos: Estudio observacional, descriptivo, transversal, realizado en 294 pacientes con diagn\u00f3stico de la infecci\u00f3n por el virus de la inmunodeficiencia humana que reciben TARGA en un hospital de referencia nacional peruano. El instrumento utilizado fue un cuestionario con validaci\u00f3n de contenido por juicio de expertos. Resultados: El promedio la edad fue 38,7 a\u00f1os, predominando el g\u00e9nero masculino en 83,3%, procedentes de Lima Centro en un 60,2%, con grado de instrucci\u00f3n secundaria en un 44,2%. Un 59,2% fueron diagnosticados en el periodo 2014-2018. Se hall\u00f3 que un 67,7% de los pacientes consume plantas medicinales, entre ellas el ajo, la manzanilla, el eucalipto y la u\u00f1a de gato. Sobre el tratamiento antirretroviral, el 63,4% se encontraban recibiendo dos inhibidores de la transcriptasa inversa an\u00e1logos de nucle\u00f3sidos y un inhibidor de la transcriptasa inversa no an\u00e1logo de nucle\u00f3sidos. Conclusi\u00f3n: Se determinaron las caracter\u00edsticas sobre el consumo de plantas medicinales en pacientes que reciben tratamiento antirretroviral fueron, quienes en su mayor\u00eda hac\u00eda uso de \u00e9stas, donde las principales eran la manzanilla, el ajo, el eucalipto, la u\u00f1a de gato y la s\u00e1bila; con ello tambi\u00e9n se pudo identificar 15 casos donde hab\u00eda probable interacci\u00f3n farmacol\u00f3gica con la u\u00f1a de gato y el ajo.\nDescargas\nM\u00e9tricas\nCitas\n\u00daltimas estad\u00edsticas sobre el estado de la epidemia de sida [Internet]. ONU SIDA. [citado el 29 de julio de 2022]. Disponible en:\n[https://www.unaids.org/es/resources/fact-sheet](https://www.unaids.org/es/resources/fact-sheet)\nOrganizaci\u00f3n Panamericana de la Salud. Terapia Antirretroviral [Internet]. [citado el 29 de julio de 2022]. Disponible en:\n[https://www.paho.org/es/temas/terapia-antirretroviral](https://www.paho.org/es/temas/terapia-antirretroviral)\nTres JC. Interacci\u00f3n entre f\u00e1rmacos y plantas medicinales. An Sist Sanit Navar [Internet]. 2006 [citado el 29 de julio de 2022];29(2):233\u201352. Disponible en:\n[https://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1137-66272006000300007&lng=es&nrm=iso&tlng=es](https://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1137-66272006000300007&lng=es&nrm=iso&tlng=es)\nGirona Brum\u00f3s L, Aldaz Pastor A, Arocas Casan V, Del-gado S\u00e1nchez O, Eyaralar Riera T, Gil Luj\u00e1n G, et al. Introducci\u00f3n a las Interacciones Farmacol\u00f3gicas [Internet]. 1ra edici\u00f3n. Espa\u00f1a: Sociedad Espa\u00f1ola de Farmacia Hospitalaria; 2011 [citado el 29 de julio de 2022]. 658\u2013693 p. Disponible en:\n[http://repositorio.ub.edu.ar/handle/123456789/5135](http://repositorio.ub.edu.ar/handle/123456789/5135)\nBoparai JK, Singh A, Gupta AK, Matreja PS, Khanna PML, Gupta V, et al. A study to determine the knowledge and level of awareness of medical undergraduates about herbal medicines and herb-drug interactions. Int J Basic Clin Pharmacol [Internet]. 2016 [citado el 29 de julio de 2022];6(1):17\u201324. doi:10.18203/2319-2003.ijbcp20164509\nAgnoletto V, Chiaffarino F, Nasta P, Rossi R, Parazzi-ni F. Use of complementary and alternative medicine in HIV-infected subjects. Complement Ther Med. 2006;14(3):193\u20139. doi:10.1016/j.ctim.2006.01.008\nV\u00e1zquez Hern\u00e1ndez M, Hurtado G\u00f3mez M, Blan-co Blanco J. Influencia de la medicina alternativa en el tratamiento antirretroviral de gran actividad. Farm Hosp [Internet]. 2009 [citado el 29 de julio de 2022];33(1):31\u20136. Disponible en:\n[https://medes.com/publication/48861](https://medes.com/publication/48861)\nUNAIDS DATA 2017 [Internet]. 2017 [citado el 29 de julio de 2022]. Disponible en:\n[https://www.unaids.org/en/resources/documents/2017/2017_data_book](https://www.unaids.org/en/resources/documents/2017/2017_data_book)\nOwen-Smith A, Diclemente R, Wingood G. Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women. AIDS Care. 2007;19(5):589\u201393. doi:10.1080/09540120701203279\nCentro Nacional de Epidemiolog\u00eda, Prevenci\u00f3n y Con-trol de Enfermedades. Situaci\u00f3n epidemiol\u00f3gica del VIH-Sida en el Per\u00fa [Internet]. 2020 [citado el 29 de julio de 2022]. Disponible en:\n[https://www.dge.gob.pe/epipublic/uploads/vih-sida/vih-sida_20209.pdf](https://www.dge.gob.pe/epipublic/uploads/vih-sida/vih-sida_20209.pdf)\nVillena-Prado JJ, Indacochea-C\u00e1ceda S. Factores epidemiol\u00f3gicos y conductas de riesgo asociados al estadio sida en pacientes mayores de 15 a\u00f1os con infecci\u00f3n VIH. Rev Soc Peru Med Interna. 2019;32(3):96\u2013103. doi:10.36393/spmi.v32i3.475\nMabou Tagne A, Biapa Nya PC, Tiotsia Tsapi A, Edingue Essoh AK, Pembouong G, Ngouadjeu Ngnintedem MA, et al. Determinants, Prevalence and Trend of Use of Medicinal Plants Among People Living with HIV: A Cross-Sectional Survey in Dschang, Cameroon. AIDS Behav. 2019;23(8):2088\u2013100. doi:10.1007/s10461-018-02388-2\nL\u00f3pez Galera RM, Ribera Pascuet E, Esteban Mur JI, Mon-toro Ronsano JB, Ju\u00e1rez Gim\u00e9nez JC. Interaction between cat\u2019s claw and protease inhibitors atazanavir, ritonavir and saquinavir. Eur J Clin Pharmacol. 2008;64(12):1235\u20136. doi:10.1007/s00228-008-0551-1\nBudzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal ex-tracts and tinctures. Phytomedicine Int J Phytother Phytopharm. 2000;7(4):273\u201382. doi:10.1016/S0944-7113(00)80044-6\nBerginc K, Kristl A. The mechanisms responsible for garlic - drug interactions and their in vivo relevance. Curr Drug Metab. 2013;14(1):90\u2013101.\nBerginc K, Trdan T, Trontelj J, Kristl A. HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy. Biopharm Drug Dispos. 2010;31(8\u20139):495\u2013505. doi:10.1002/bdd.730\nPublicado\nC\u00f3mo citar\nN\u00famero\nSecci\u00f3n\nLicencia\nDerechos de autor 2022 Kimberly Rashel Ch\u00e1vez Bravo, Joseph Arthuro Pinto Oblitas\nEsta obra est\u00e1 bajo una licencia internacional\n[Creative Commons Atribuci\u00f3n 4.0](https://creativecommons.org/licenses/by/4.0/).\nLa revista utiliza una licencia\n[Creative Commons](https://creativecommons.org/licenses/) para mostrar a los lectores y usuarios c\u00f3mo se pueden utilizar los contenidos publicados.\nLos contenidos publicados en esta revista est\u00e1n bajo una\n[licencia CC-BY 4.0](http://creativecommons.org/licenses/by/4.0/). Esta licencia permite:\n- Compartir \u2014 copiar y redistribuir el material en cualquier medio o formato\n- Adaptar \u2014 remezclar, transformar y construir a partir del material para cualquier prop\u00f3sito, incluso comercialmente.\nBajo los siguientes t\u00e9rminos:\n-\nAtribuci\u00f3n \u2014 Usted debe dar\n[cr\u00e9dito de manera adecuada](https://creativecommons.org/licenses/by/4.0/deed.es), brindar un enlace a la licencia, e [indicar si se han realizado cambios](https://creativecommons.org/licenses/by/4.0/deed.es). Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#siteNav", "#pkp_content_footer", "\t\t\t\t\t\thttp://rpmi.pe/index.php/rpmi/index\n\t\t\t\t\t", null, "https://rpmi.pe/index.php/rpmi/index", "http://rpmi.pe/index.php/rpmi/about", "http://rpmi.pe/index.php/rpmi/about", "http://rpmi.pe/index.php/rpmi/about/editorialTeam", "http://rpmi.pe/index.php/rpmi/archiving", "http://rpmi.pe/index.php/rpmi/copyrightLicensing", "http://rpmi.pe/index.php/rpmi/about/privacy", "http://rpmi.pe/index.php/rpmi/about/contact", "https://rpmi.pe/index.php/rpmi/", "http://rpmi.pe/index.php/rpmi/issue/current", "http://rpmi.pe/index.php/rpmi/issue/archive", "https://rpmi.pe/index.php/rpmi/", "https://rpmi.pe/index.php/rpmi/about/submissions#authorGuidelines", "http://rpmi.pe/index.php/rpmi/ethics", "http://rpmi.pe/index.php/rpmi/peerReview", "http://rpmi.pe/index.php/rpmi/openAccessPolicy", "https://rpmi.pe/index.php/rpmi/", "http://rpmi.pe/index.php/rpmi/webAnalytics", "http://rpmi.pe/index.php/rpmi/search", "https://rpmi.pe/index.php/rpmi/", "http://rpmi.pe/index.php/rpmi/login", "http://rpmi.pe/index.php/rpmi/user/register", null, "http://rpmi.pe/index.php/rpmi/index", "http://rpmi.pe/index.php/rpmi/issue/archive", "http://rpmi.pe/index.php/rpmi/issue/view/2", "https://orcid.org/0000-0002-7744-1635", "https://doi.org/10.26722/rpmi.2022.v7n3.13", "https://plu.mx/plum/a/?doi=10.26722/rpmi.2022.v7n3.13", "https://www.unaids.org/es/resources/fact-sheet", "https://www.paho.org/es/temas/terapia-antirretroviral", "https://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1137-66272006000300007&lng=es&nrm=iso&tlng=es", "http://repositorio.ub.edu.ar/handle/123456789/5135", "https://medes.com/publication/48861", "https://www.unaids.org/en/resources/documents/2017/2017_data_book", "https://www.dge.gob.pe/epipublic/uploads/vih-sida/vih-sida_20209.pdf", "http://rpmi.pe/index.php/rpmi/issue/view/2", "http://rpmi.pe/index.php/rpmi/article/view/13/13", "http://rpmi.pe/index.php/rpmi/article/view/13/697", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/acm-sig-proceedings?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/acs-nano?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/apa?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/chicago-author-date?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/harvard-cite-them-right?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/ieee?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/modern-language-association?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/get/vancouver?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/download/ris?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/citationstylelanguage/download/bibtex?submissionId=13&publicationId=13", "http://rpmi.pe/index.php/rpmi/issue/view/2", "https://creativecommons.org/licenses/by/4.0/", "https://creativecommons.org/licenses/by/4.0/", "https://creativecommons.org/licenses/", "http://creativecommons.org/licenses/by/4.0/", "https://creativecommons.org/licenses/by/4.0/deed.es", "https://creativecommons.org/licenses/by/4.0/deed.es", null, null, null, null, null, null, "https://scholar.google.com/scholar?q=10.26722/rpmi.2022.v7n3.13", "http://europepmc.org/search?scope=fulltext&query=(REF:10.26722/rpmi.2022.v7n3.13)", "http://rpmi.pe/index.php/rpmi/user/setLocale/en_US?source=%2Findex.php%2Frpmi%2Farticle%2Fview%2F13", "http://rpmi.pe/index.php/rpmi/user/setLocale/es_ES?source=%2Findex.php%2Frpmi%2Farticle%2Fview%2F13", "http://rpmi.pe/index.php/rpmi/about/submissions", "https://portal.issn.org/resource/ISSN/2415-2692", null, "http://portal.essalud.gob.pe/", "https://web.facebook.com/profile.php?id=100068930948225", "https://twitter.com/mec_rpmi", "http://rpmi.pe/index.php/rpmi/gateway/plugin/WebFeedGatewayPlugin/atom", "http://rpmi.pe/index.php/rpmi/gateway/plugin/WebFeedGatewayPlugin/rss2", "http://rpmi.pe/index.php/rpmi/gateway/plugin/WebFeedGatewayPlugin/rss", "http://rpmi.pe/index.php/rpmi/information/readers", "http://rpmi.pe/index.php/rpmi/information/authors", "http://rpmi.pe/index.php/rpmi/information/librarians", null, "http://creativecommons.org/licenses/by/4.0/", "http://creativecommons.org/licenses/by/4.0/", "http://rpmi.pe/index.php/rpmi/about/aboutThisPublishingSystem"]}